Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

5 results
Display

Surgical Management of Recurrent Cervical Cancer

Selman AE, Copeland L

The majority of patients with recurrent cervical cancer are incurable and treatment is based on the type of primary therapy delivered. Only a very small percentage of the patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma

Kim JW, Kim YT, Kim DK

Neoadjuvant chemotherapy prior to definitive radical surgery or radiotherapy may be effective in reducing tumor volume or clinical stage and may even enhance pelvic control and survival. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors

Park TK, Kim SN, Kim SW, Kim GE, Suh CO

The aim of this study was to evaluate the survival of 395 previously untreated cervical cancer patients with at least one high risk factor following concurrent chemoradiation and to assess...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adjuvant therapy in cervical cancer patients with high risk factors

Park TK

Neoadjuvant and adjuvant chemotherapies are used adjunctively with surgery or radiation and are among the treatment options that are now employed for reducing treatment failure in early-stage cervical cancers with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overdose of vincristine: experience with a patient

Chae L, Moon HS, Kim SC

Vincristine, referred to as a vinka alkaloid, has been used as a component of the various chemotherapeutic regimens. The major side effects of the usual dosage of vincristine are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr